Skip to main content

Animations

MJFF Publications

4211 - 4220 of 8823 Results
Title
Year
  • Year
  • 2015
  • 2016
  • 2015
  • 2014
  • 2010
  • 2010
  • 2015
  • 2023
  • 2014
  • 2013
  • Summary Details
    OPEN
    Title: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/ncomms8314
    Citation Count: 280
  • Summary Details
    OPEN
    Title: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/ncomms10332
    Citation Count: 94
  • Summary Details
    OPEN
    Title: O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
    Journal Name: Nature Chemistry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchem.2361
    Citation Count: 253
  • Summary Details
    OPEN
    Title: A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-014-0294-x
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-010-0664-3
    Citation Count: 795
  • Summary Details
    OPEN
    Title: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-015-1526-9
    Citation Count: 158
  • Summary Details
    OPEN
    Title: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/anie.202309306
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.
    Journal Name: Neuropsychology
    Publisher: American Psychological Association (APA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1037/neu0000158
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2013.06.046
    Citation Count: 345
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.